Global Abortion Drugs Market: Regional Analysis
North America is expected to hold the largest market share in the global abortion drugs market, owing to increasing approval of drugs for the termination of pregnancy, which is driving the global abortion drugs market growth. For instance, in April 2019, the U.S Food and Drug Administration (FDA) approved GenBioPro, Inc.’s generic Mifeprex medicine, which is used for the termination of intrauterine pregnancy through 70 days gestation. This approval reflects FDA’s determination that GenBioPro’s product, Mifepristone Tablets, 200 mg, is therapeutically equivalent to Mifeprex as well as can be safely substituted for Mifeprex.
Abortion Drugs Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients